Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
US10316018B2 · kind B2 · utility
1Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2018 |
| Grant date | Jun 11, 2019 |
| Priority date | — |
| Expiry date | Nov 30, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.